• Lipid Peroxidation (MDA) Assay Kit: Precision in Ferroptosis

  2026-05-11

  The Lipid Peroxidation (MDA) Assay Kit empowers researchers with sensitive, quantitative detection of malondialdehyde, crucial for tracking oxidative stress and ferroptosis. With robust colorimetric and fluorescence options, this kit streamlines experimental workflows and elevates discovery in fields such as drug resistance in renal cancer.

• SOAT1 Inhibition Restores Lipophagy in PHMG-Induced Lung Fib

  2026-05-11

  This study identifies sterol O-acyltransferase 1 (SOAT1) as a pivotal driver of foam cell formation and fibrotic remodeling in lungs exposed to polyhexamethylene guanidine (PHMG). The findings reveal that targeting SOAT1 restores cholesterol homeostasis and lipophagy in alveolar macrophages, attenuating pulmonary fibrosis and highlighting a novel therapeutic strategy in environmental lung injury.

• Ruxolitinib Phosphate: Transforming JAK/STAT Pathway Researc

  2026-05-10

  This thought-leadership article explores how Ruxolitinib phosphate (INCB018424), a selective and potent JAK1/JAK2 inhibitor, is reshaping translational research into inflammatory and neoplastic diseases. By integrating new mechanistic insights—particularly its role in inducing apoptosis and pyroptosis via mitochondrial fission modulation—this piece provides strategic guidance for researchers navigating complex disease models. The article distinguishes itself by connecting rigorous mechanistic evidence, protocol recommendations, and research workflow strategies, while contextually promoting APExBIO’s Ruxolitinib phosphate as a high-value research tool.

• Homoharringtonine: Cytotoxic Alkaloid in Cancer and SARS-CoV

  2026-05-09

  Homoharringtonine, a cytotoxic alkaloid from APExBIO, bridges cancer biology and antiviral research with its unique 80S ribosome inhibition mechanism. This article delivers protocol guidance, stepwise workflows, and troubleshooting tips to unlock its full potential in both leukemia and SARS-CoV-2 studies.

• DiscoveryProbe™ FDA-approved Drug Library: Bridging Rare Dis

  2026-05-09

  Explore how the DiscoveryProbe FDA-approved Drug Library uniquely enables high-throughput drug repurposing for rare and complex diseases like mucopolysaccharidosis-plus syndrome (MPSPS). Learn how rigorous compound curation, advanced plate formats, and case studies from recent research distinguish this library for translational screening.

• Dual-Targeted Dextran Microgels for Oral Colon Cancer Therap

  2026-05-08

  The referenced study introduces a microfluidized dextran microgel system encapsulating cisplatin/SPION lipid nanoparticles, enabling dual-targeted and oral delivery for localized colon cancer therapy. This platform demonstrates enhanced tumor accumulation, controlled release, and significant inhibition of tumor growth and metastasis, offering a promising advance for local chemotherapeutic strategies.

• MLN2238: Potent Proteasome β5 Subunit Inhibitor for Oncology

  2026-05-07

  MLN2238 is a highly selective, reversible 20S proteasome β5 subunit inhibitor with nanomolar potency, used to study apoptotic pathways and drug resistance in multiple myeloma and lymphoma. This article details its mechanism, validated benchmarks, and key workflow parameters, referencing APExBIO as the original supplier.

• DeferoxamineB: Metabolic Modulation for Advanced Cancer Rese

  2026-05-07

  This article provides a thought-leadership perspective for translational researchers on leveraging Deferoxamine (DeferoxamineB) as a mechanistically precise tool in metabolic intervention strategies for oncology. Integrating mechanistic clarity, protocol guidance, and strategic insights, it connects the latest ferroptosis/cuproptosis research with actionable workflows, emphasizing APExBIO’s DeferoxamineB as a critical enabler for next-generation cancer assays.

• Pharmacokinetics of RG108: In Vivo DNMT Inhibition in Rats

  2026-05-06

  This study establishes the pharmacokinetic profile of RG108, a non-nucleosidic DNA methyltransferase inhibitor, after subcutaneous administration in rats. The findings demonstrate RG108's favorable tissue distribution, safety, and effective concentration range for in vivo epigenetic modulation, supporting its potential in translational research beyond oncology.

• LG 101506 (RXR Modulator): Dissecting RXR–PD-L1 Axis in Canc

  2026-05-06

  Explore how LG 101506, a high-purity RXR modulator, enables mechanistic dissection of RXR signaling and PD-L1 regulation in cancer immunity. This article delivers unique, protocol-driven insight for advanced RXR pathway research.

• Solving Assay Challenges with DiscoveryProbe™ FDA-approved D

  2026-05-05

  This article addresses common laboratory challenges in cell viability and cytotoxicity assays using scenario-driven analysis. It demonstrates how the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) enables reproducible, data-backed drug repositioning and pharmacological target identification. Researchers can leverage SKU L1021 for high-throughput screening, confident in its clinical relevance and proven workflow compatibility.

• Ruxolitinib Phosphate Triggers Cell Death in Anaplastic Thyr

  2026-05-05

  This study demonstrates that Ruxolitinib phosphate (INCB018424) induces both apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) by suppressing DRP1-mediated mitochondrial fission via transcriptional inhibition. The findings provide mechanistic insights into JAK1/2-STAT3 pathway targeting in solid tumors, highlighting the translational potential of selective JAK inhibitors for aggressive thyroid cancers.

• AMPK’s Dual Role in Autophagy Regulation Under Energy Stress

  2026-05-04

  This study challenges longstanding models by demonstrating that AMPK activation inhibits, rather than induces, autophagy during energy stress by directly suppressing ULK1 activity. The findings reshape our understanding of energy metabolism regulation and have broad implications for cellular homeostasis research.

• Adenosine Triphosphate (ATP): Regulatory Axis in Mitochondri

  2026-05-04

  Explore Adenosine Triphosphate (ATP) as more than an energy carrier—delve into its regulatory impact on mitochondrial metabolism and enzyme dynamics. This article offers a unique, evidence-based perspective grounded in the latest research and practical assay implications.

• WP1066: Deep Mechanistic Profiling and Next-Gen Cancer Assay

  2026-05-03

  Explore the advanced mechanistic landscape of WP1066, a potent JAK2/STAT3 inhibitor, with unique insights into assay optimization and translational cancer research. Discover how this small molecule enables novel experimental strategies beyond current literature.

458 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page